Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Sectra brings mobile mammo to Germany

Sectra has implemented its MicroDose Mammography technology into a mobile screening unit in Germany.

Cancer: Initial prostate cancer treatment decisions affect long-term costs

The cost patterns of prostate cancer treatment can vary widely based on initial treatment choice, and treatments that may be less expensive in the short-term may have higher long-term costs, according to a study published online Aug. 23 in Cancer.

JECCR: Microsoft Excel-based algorithm predicts cancer prognosis

Using readily available computer programs such as Microsoft Excel, researchers can quickly generate valuable gene signatures for predicting breast cancer without specialized software or extensive bioinformatics training, according to an article published online Sept. 1 in Journal of Experimental & Clinical Cancer Research.

CMS increases 2011 reimbursements for SynCardia artificial heart

The Centers for Medicare & Medicaid Services (CMS) has approved new technology add-on payments of up to $53,000 for the SynCardia temporary Total Artificial Heart (TAH-t) through its 2011 Hospital Inpatient Prospective Payment System final rule. The decision is effective Oct. 1.

Swiss patient treated with Varian's Gated RapidArc technology

Radiotherapy provider Varian Medical Systems has treated its first patient with its Gated RapidArc system, a radiotherapy treatment technology that monitors patient breathing and compensates for tumor motion.

ESC: For MI patients, fatty acid intake doesn't curb CV risk

Administering low-dose supplements of n-3 fatty acidseicosapentaenoic acid and docosahexaenoic acid or alpha-linolenic aciddid not significantly alter the rates of major cardiovascular (CV) events among MI patients, according to the results of the Alpha Omega trial presented this week at the European Society of Cardiology (ESC) meeting in Stockholm, and simultaneously published online Aug. 29 in the New England Journal of Medicine.

Calif. legislature seeks to restore mammo screening program

The California State Legislature has approved a bill to save the states mammogram program--Every Woman Counts--with a vote of 34-0 from the Senate and 75-0 in the state assembly last week.

FDA warns of mammo quality performed at Florida facility

The FDA has alerted the public to problems associated with the quality of mammograms performed at the Medisound facility in Kissimmee, Fla

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.